Targeting cell signaling pathways for drug discovery: an old lock needs a new key.

Abstract excerpt

In this age of targeted therapy, the failure of most current drug-discovery efforts to yield safe, effective, and inexpensive drugs has generated widespread concern. Successful drug development has been stymied by a general focus on target selection rather than clinical safety and efficacy. The very process of validating the targets themselves is inefficient and in many cases leads to drugs having poor efficacy...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antigens, CD20
• Share to Chemistry, Pharmaceutical